Search clinical trials for: Pathfinder

Total 33 results

Mind Mental Health Hong Kong Limited
Chinese University of Hong Kong

Recruiting

Evaluation of Training Curriculum and Service of Improving Access to Community Therapies (iACT)

Depression | Stress | Anxiety | Distress, Emotional | Mental Health Issue

China
Henry Ford Health System
Wayne State University

Recruiting

Project 4: ACHIEVE PATHFINDER (PATHFINDER)

Heart Failure

United States
University of Calgary
Alimentiv Inc.

Recruiting

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Crohn Disease

Canada
Beth Israel Deaconess Medical Center

Recruiting

Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies (PATHFINDERII)

Pain | Postoperative Delirium | Neurocognitive Dysfunction | Hemodynamic Instability

United States
GRAIL, LLC

Recruiting

PATHFINDER 2: A Multi-Cancer Early Detection Study

Cancer | Early Detection of Cancer

United States, Canada
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A (pathfinder™6)

Congenital Bleeding Disorder | Haemophilia A

United States, Spain, Australia, France, Thailand, Italy, Malaysia, Austria, Greece, Japan, Taiwan, Canada, Israel, Algeria, Argentina, Bulgaria, Germany, Romania
George Washington University
University of Oklahoma; Addis Ababa University; Pathfinder International; Overseas... and other collaborators

Active, not recruiting

GAGE Act With Her-Ethiopia Evaluation

Adolescent Behavior | Gender

Ethiopia
Baylor College of Medicine

Completed

Pathfinder Registry

Gastrointestinal Polyps

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) (Pathfinder10)

Haemophilia A

China
Novo Nordisk A/S

Enrolling by invitation

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® (pathfinder9)

Haemophilia A

Austria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
MedSIR
Hoffmann-La Roche

Completed

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer (PATHFINDER)

Triple Negative Breast Cancer

Spain, Portugal
Blueprint Medicines Corporation

Active, not recruiting

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm

United States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
HLT Inc.

Withdrawn

HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation (RIVAL - AR EFS)

Aortic Regurgitation

United States
University of California, San Diego
Bill and Melinda Gates Foundation; Pathfinder International

Completed

Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger (IMPACT-RMA)

Contraception

United States, Niger
Angiodynamics, Inc.

Active, not recruiting

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I)

Peripheral Arterial Disease | PAD | Infrainguinal Peripheral Artery Disease

United States
The Neurokinex Charitable Trust
International Spinal Research Trust

Completed

Spinal Stimulation in Chronic Spinal Cord Injury

Spinal Cord Injuries

United Kingdom
Novo Nordisk A/S

Completed

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A (pathfinder8)

Congenital Bleeding Disorder | Haemophilia A

United States, Netherlands, Spain, Switzerland, Taiwan, Turkey, United Kingdom, Croatia, Germany, Brazil, France, Japan, Australia, Hungary, Israel, Korea, Republic of, Lithuania, Portugal, Ukraine, Greece, Italy, Denmark, Norway, Canada and more
RAND
University of California, Los Angeles; Bill and Melinda Gates Foundation; Pathfinder...

Completed

Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan

Family Planning Services

United States
University of Erlangen-Nürnberg Medical School
AOK Bayern; Federal Joint Committee; Friedrich-Alexander-Universität Erlangen-Nürnberg and other collaborators

Completed

Improvement of Transition From Hospital to Home for Older Patients in Germany (TIGER)

Geriatric Patients in the Transition From Hospital to Home

Germany
Beth Israel Deaconess Medical Center

Completed

The PATHFINDER Study: A Feasibility Trial (PATHFINDER)

Coronary Artery Disease | Delirium

United States
Novo Nordisk A/S

Completed

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A (pathfinder™5)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy
Novo Nordisk A/S

Completed

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A (pathfinder™2)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, Japan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Puerto Rico, Norway, Korea, Republic of, Bulgaria, Russian...
Novo Nordisk A/S

Completed

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. (pathfinder™3)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, United Kingdom, Croatia, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Italy, Japan, Norway, Bulgaria
VA Northern California Health Care System
United States Department of Defense

Unknown

Remotely Deployed TBI Study (RD)

Brain Injury

United States
Novo Nordisk A/S

Completed

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A (pathfinder™7)

Congenital Bleeding Disorder | Haemophilia A

United States, Netherlands, Spain, Germany, France, Denmark
Novo Nordisk A/S

Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A (pathfinder™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
MeMed Diagnostics Ltd.
University Hospital, Geneva; Bnai Zion Medical Center

Completed

A Retrospective, Blinded Validation of a Host-response Based Diagnostics (PATHFINDER)

Respiratory Tract Infections | Gastroenteritis | Fever | Urinary Tract Infections | Arthritis, Infectious

Israel
Pathfinder Therapeutics

Terminated

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

Liver Cancer

United States
Pathfinder Therapeutics

Completed

Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures

Liver Cancer

United States
Pathfinder Therapeutics

Completed

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

Liver Cancer

United States
Pathfinder Therapeutics

Completed

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

Liver Cancer

United States
Pathfinder Therapeutics
National Institutes of Health (NIH)

Completed

Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer

Liver Cancer

United States
FHI 360
Pathfinder International

Completed

Integrating Family Planning Into Postabortion Care

Postabortion Care

Kenya

Search clinical trials for: Pathfinder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations